Restore Flow Allografts
Restore Flow Allografts's email is ddunston@restoreflow.com
and
Restore Flow Allografts's phone number is (847)462-2191
.
Restore Flow Allografts, LLC operates in the healthcare industry. The company was incorporated in 2013 and is based in Chicago, Illinois....
View Top Employees for Restore Flow Allografts
Website | restoreflow.com | |
Industry | Financial Services | |
Location | Chicago, Illinois, United States | |
Employees | 3 |
HQ | 8600 W. Catalpa Avenue | |
Phone | (847)462-2191 | |
ddunston@restoreflow.com | ||
Funding | 750,000 USD |
Website | restoreflow.com | |
Industry | Financial Services | |
Location | Chicago, Illinois, United States | |
Employees | 3 | |
linkedin.com/company/restore-flow-allografts | ||
HQ | 8600 W. Catalpa Avenue | |
Phone | (847)462-2191 | |
ddunston@restoreflow.com | ||
Funding | 750,000 USD |
Restore Flow Allografts Questions
Where are Restore Flow Allografts's headquarters?
Restore Flow Allografts's headquarters are in 8600 W. Catalpa Avenue
What is Restore Flow Allografts's phone number?
Restore Flow Allografts's phone number is (847)462-2191
What is Restore Flow Allografts's official website?
Restore Flow Allografts's website is restoreflow.com
How many employees are working in Restore Flow Allografts right now?
Restore Flow Allografts has
3 employees.
View the Email and Phone Numbers for all 3 working at Restore Flow Allografts.
What is Restore Flow Allografts's industry?
Restore Flow Allografts's industry is
Financial Services
What is Restore Flow Allografts's email address?
Restore Flow Allografts's email address is ddunston@restoreflow.com
What are Restore Flow Allografts's categories?
Restore Flow Allografts's categories are Biotechnology, Health Care, Life Science, Medical Device
What is Restore Flow Allografts's location?
Restore Flow Allografts's location is
Chicago, Illinois, United States
What is Restore Flow Allografts's funding?
Restore Flow Allografts's funding is 750,000 USD
What is Restore Flow Allografts's current status?
Restore Flow Allografts's current status is acquired